Welcome to Tymora Analytical Operations!

Tymora Analytical Operations provides new research services, products, and reagents to the life science R&D organizations. Tymora has developed nanoscale platform technologies – with PolyMAC and pIMAGO as the lead products – for unmet needs in analysis of protein phosphorylation that relates to the onset of numerous diseases, most notably cancer.

Welcome to Tymora Analytical Operations!

Tymora Analytical Operations provides new research services, products, and reagents to the life science R&D organizations. Tymora has developed nanoscale platform technologies – with PolyMAC and pIMAGO as the lead products – for unmet needs in analysis of protein phosphorylation that relates to the onset of numerous diseases, most notably cancer.

Proteomics Services

Our recently published manuscript in PNAS demonstrates the feasibility of identifying phosphoproteins in plasma-derived vesicles. Our goal is to help doctors and scientists provide earlier diagnoses and more effective treatments for cancer and other abnormalities.

 

Learn more

Products

Detection of protein phosphorylation is essential in understanding an organism’s signaling pathways and preventing and treating cancer and other abnormalities. This is why we offer PolyMAC and pIMAGO, effective R&D products for phosphorylation analysis.

 

Learn more

Collaborate

Contact us for more information or to discuss opportunities available.

 

Learn more
Contact us

pIMAGO

Universal non-antibody detection of phosphoproteins.
Available formats include:
Western Blot, Microplate, & Microarray

One-Step PolyMAC

The binding of phosphopeptides and a covalent capture occur in a single step with Tymora’s PolyMAC product. Utilize PolyMAC for effective phosphopeptide enrichment.

Interested in collaboration?

Contact us for more information or to discuss opportunities available.

Tymora News

GenomeWeb – Tymora developing extracellular vesicle-based phosphoproteomic liquid biopsies

Researchers at Purdue University and Tymora Analytical Operations have developed a method for blood- and urine-based phosphoproteomic analysis that they aim to use to detect and manage various cancers.

Read more

Purdue start-up advances simple blood, urine tests to detect, monitor early-stage cancers

Researchers at Purdue-affiliated company who discovered a way to detect and monitor breast cancer using a simple blood test and bladder cancer using a urine test believe the process can be expanded to diagnose a myriad of early-stage cancers.

Read more

Nanopolymer-modified glycoprotein array can pinpoint cancer

In a recently published study, Purdue University and Tymora Analytical researchers have developed a high-throughput glycoprotein array and applied it to bladder cancer biomarker discovery from urine.

Read more

USA Today – Could a simple blood test screen for cancer?

Researchers at Purdue University and Tymora Analytical have developed a process to study blood phosphoproteins that could open the door to detecting and monitoring cancer in patients with a simple blood test.

Read more

Recent publication by Tymora Analytical featured on the cover of ChemBioChem

Our paper, “Multiplexed Imaging of Protein Phosphorylation on Membranes Based on Ti(IV) Functionalized Nanopolymers,” was recently featured as the cover of ChemBioChem for their current issue published on May 17, 2016, Volume 17 Issue 10.

Read more

Tymora receives $225,000 grant to advance prostate cancer research

Federal funding will help a Purdue-affiliated company research technology that could lead to a new way to distinguish aggressive forms of prostate cancer from indolent forms of the disease.

Read more